Long Position on CBM @ $40.20 on 4/30/2015 (Rumor)

Cambrex Corporation (CBM) is  a life sciences company.

The firm provides various products and services for the development and commercialization of new and generic therapeutics worldwide. The company’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products.

It serves generic drug companies, and companies that discover and commercialize small molecule human therapeutics.

The company sells its products directly, as well as through independent agents. Shares have formed a bullish "flag" ahead of the company's earnings report on tomorrow. The formation is supported by the stock's 30-day moving average. Estimates call for estimates of 23 cents per share on revenue of $70.1M.

Higher share prices are expected for this stock.

52-Weeks Trading Range: $15.76 - $44.22

Entry Point: $40.20

Stop Loss: $38.11

Target Price: $44.30

Updates

5/5/2015 12:12:15 PM

CBM closed at $36.00

Position closed on 5/5/2015 at price of $36.00 with a -10.45% loss in 5 days.

Back to Portfolio